BMO Capital lowered the firm’s price target on UiPath (PATH) to $12.50 from $15.50 and keeps a Market Perform rating on the shares. The company reported a “reasonable” quarter as net new annual recurring revenue increased by $30M vs. the firm’s estimate of $25M – a 30% y/y decline, the analyst tells investors in a research note. BMO adds however that while UiPath reported having over 450 customers deploying agentic capabilities, it is too early and the market will be competitive to incorporate automation in its long-term forecast.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- UiPath price target lowered to $12 from $13 at Truist
- UiPath: Stabilization Amidst Challenges and Future Growth Potential – Hold Rating
- UiPath’s Strong Performance and Cautious Outlook Lead to Hold Rating
- UiPath assumed with a Neutral at DA Davidson
- Cautious Outlook on UiPath: Sell Rating Due to Underwhelming Growth and Margin